Driving Health Innovation: Harnessing the Power and Value of Real-World Evidence

October 21 – 22, 2019

MaRS Discovery District

101 College Street Toronto, Ontario




Keynote – Beyond the 1%: Knowing when and how to use RWD to support medical product approvals and use

session 1 – Privacy, data sharing and access

session 2 – Rare drug reimbursement: Policy solutions to patient access (slides not available)

session 3 – UNTAPPED: Innovative ways to use big data in healthcare

session 4 – A method to the madness: Innovative RWE methods that are changing the game (slides not available)

session 5 – Oral presentation of top-ranked research abstracts

session 6 – Where Real World Evidence (RWE) can be used to support suboptimal evidence across all clinical development phases

session 7 – How Canada’s health and pharmacare programs can leverage real-world data and strategic partnerships to address the challenges and opportunities of an aging population and new health technologies

session 8 – The era of artificial intelligence in healthcare

session 9– RWE to support outcome-based agreements in Canada: A case study using patient support program data

session 10 – The path to the future: updates from the CADTH Core Action Team (CAT) on the progress of RWE in Canada

Abstracts presented at the Conference are available online

J Popul Ther Clin Pharmacol Vol 26(3):e14, 2019

JPTCP_2019_CAPT_final Oct 28


2019 Kris Schindel Award Recipient, Allan F. Gillman 

Best Oral Poster was presented to Brittany Humphries,

Impact of patient-target financial incentives on healthcare costs: A systematic review of randomized controlled trials

Department of Health Research Methods, Evidence, and Impact, McMaster University


Best Poster was presented to Jason Hu,

Baseline Bone Density Testing in Men Starting Androgen Deprivation Therapy for Prostate Cancer

Division of Urology, McGill University